Hypophosphatemia after high-dose iron repletion with ferric carboxymaltose and ferric derisomaltose-the randomized controlled HOMe aFers study.

Insa E EmrichF LizziJ D SiegelS Seiler-MusslerC UkenaD Kaddu-MulindwaR D'AmelioS WagenpfeilV M BrandenburgM BöhmD FliserG H Heine

Published in: BMC medicine (2020)

Clinical Trials.gov NCT02905539. Registered on 8 September 2016. 2015-004808-36 (EudraCT Number) U1111-1176-4563 (WHO Universal Trial Number) DRKS00010766 (Deutsches Register Klinischer Studien).

Keyphrases

iron deficiency
clinical trial
phase iii
phase ii
high dose
open label
double blind
study protocol
healthcare
low dose
placebo controlled
stem cell transplantation